Compare TEVA & CVNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | CVNA |
|---|---|---|
| Founded | 1901 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 46.8B |
| IPO Year | 1996 | 2017 |
| Metric | TEVA | CVNA |
|---|---|---|
| Price | $41.71 | $72.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 24 |
| Target Price | $48.94 | ★ $81.14 |
| AVG Volume (30 Days) | 6.6M | ★ 8.9M |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 183.45 | ★ 431.45 |
| EPS | 0.02 | ★ 8.45 |
| Revenue | N/A | ★ $20,322,000,000.00 |
| Revenue This Year | N/A | $46.30 |
| Revenue Next Year | $3.29 | $26.07 |
| P/E Ratio | $2,092.50 | ★ $9.18 |
| Revenue Growth | N/A | ★ 48.63 |
| 52 Week Low | $23.61 | $55.92 |
| 52 Week High | $43.34 | $486.89 |
| Indicator | TEVA | CVNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 72.91 |
| Support Level | $38.55 | $62.23 |
| Resistance Level | N/A | $418.77 |
| Average True Range (ATR) | 1.15 | 3.07 |
| MACD | 0.04 | 2.19 |
| Stochastic Oscillator | 64.82 | 95.97 |
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.